Matz, Jonathan.
"Vapendavir significantly improves upper respiratory symptoms of naturally acquired rhinovirus infection in asthmatic adults: Results of a phase 2 clinical trial." European Respiratory Journal
42.Suppl 57
(2013):
1493.
Web. 23 April. 2024.